by Safe RX Compounding | Jan 19, 2026 | Featured
January 15, 2026 | Julian Gill The company declined to provide its full response to the FDA but said it “addressed the agency’s feedback and will continue to regularly communicate with FDA about any remaining commitments.” … The FDA inspected the larger...
by Safe RX Compounding | Jan 19, 2026 | Featured
By Maggie Fick and Mrinalika Roy January 13, 20267:17 AM ESTUpdated January 13, 2026 Jan 12 (Reuters) – Novo Nordisk (NOVOb.CO), opens new tab CEO Mike Doustdar said on Monday as many as 1.5 million patients in the U.S. may be using...
by Safe RX Compounding | Jan 19, 2026 | Featured
Peter Pitts RCHealth | January 16, 2026 If the SAFE Drugs Act of 2025 makes you nervous, you should ask yourself why. Earlier this year, the Center for Medicine in the Public Interest (CMPI) published a report warning that large-scale, copycat drug...
